Get 20% lifetime commission for referring investors to digrin.com here.

Checkpoint Therapeutics, Inc. (CKPT) Financials

Stock symbol CKPT is outdated, potentially delisted? Maybe it is available on other exchange?

CKPT Assets vs Liabilities

Date	Assets	Liabilities
Sept. 30, 2024	5.2 million	17.8 million
June 30, 2024	5.7 million	21.4 million
March 31, 2024	12.0 million	22.2 million
Dec. 31, 2023	5.4 million	18.4 million

CKPT Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
Sept. 30, 2024	-11.2 million	1.6 million
June 30, 2024	-6.2 million	567000
March 31, 2024	-6.5 million	709000
Dec. 31, 2023	-6.8 million	672000

CKPT Net Income

No data available :(

CKPT Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
Sept. 30, 2024	4.7 million	-	-
June 30, 2024	5.0 million	-	-
March 31, 2024	11.2 million	-	-
Dec. 31, 2023	4.9 million	-	-

CKPT Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
Sept. 30, 2024	43.2 million
June 30, 2024	36.5 million
March 31, 2024	32.9 million
Dec. 31, 2023	27.3 million

CKPT Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
Sept. 30, 2024	-	6.4 million	3.4 million	-
June 30, 2024	-	4.5 million	2.2 million	-
March 31, 2024	-	8.5 million	2.5 million	100000
Dec. 31, 2023	-	8.3 million	1.9 million	300000

CKPT Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
Sept. 30, 2024	-	-
June 30, 2024	41000	4.5 million
March 31, 2024	-	8.5 million
Dec. 31, 2023	6000	8.3 million

CKPT

Price: $4.26

52 week price:

1.80

4.50

Earnings Per Share: -1.28 USD

P/E Ratio: -3.33

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 87100

Ebitda: -5.9 million

Market Capitalization: 367.7 million

Links:

CKPT on Yahoo Finance